PURPOSE: Genistein, the major bioactive isoflavone of soybeans, acts as a radiosensitizer for prostate cancer (PCa) both in vitro and in vivo. However, pure genistein promoted increased metastasis to lymph nodes. A mixture of soy isoflavones (genistein, daidzein, glycitein) did not cause increased metastasis, but potentiated radiotherapy. We tested whether daidzein could negate genistein-induced metastasis. METHODS: Mice bearing PC-3 prostate tumors were treated with daidzein, genistein or both, and with tumor irradiation. Primary tumors and metastases were evaluated. The effects of each isoflavone and soy were compared in vitro using PC-3 (AR-) and C4-2B (AR+) androgen-independent PCa cell lines. RESULTS: Daidzein did not increase metastasis to lymph nodes and acted as a radiosensitizer for prostate tumors. Daidzein inhibited cell growth and enhanced radiation in vitro but at doses higher than genistein or soy. Daidzein caused milder effects on inhibition of expression and/or activities of APE1/Ref-1, HIF-1alpha and NF-kappaB in PC-3 and C4-2B cells. CONCLUSIONS: Daidzein could be the component of soy that protects against genistein-induced metastasis. Daidzein inhibited cell growth and synergized with radiation, affecting APE1/Ref-1, NF-kappaB and HIF-1alpha, but at lower levels than genistein and soy, in AR+ and AR- PCa cells, suggesting it is an AR-independent mechanism.
PURPOSE:Genistein, the major bioactive isoflavone of soybeans, acts as a radiosensitizer for prostate cancer (PCa) both in vitro and in vivo. However, pure genistein promoted increased metastasis to lymph nodes. A mixture of soy isoflavones (genistein, daidzein, glycitein) did not cause increased metastasis, but potentiated radiotherapy. We tested whether daidzein could negate genistein-induced metastasis. METHODS:Mice bearing PC-3 prostate tumors were treated with daidzein, genistein or both, and with tumor irradiation. Primary tumors and metastases were evaluated. The effects of each isoflavone and soy were compared in vitro using PC-3 (AR-) and C4-2B (AR+) androgen-independent PCa cell lines. RESULTS:Daidzein did not increase metastasis to lymph nodes and acted as a radiosensitizer for prostate tumors. Daidzein inhibited cell growth and enhanced radiation in vitro but at doses higher than genistein or soy. Daidzein caused milder effects on inhibition of expression and/or activities of APE1/Ref-1, HIF-1alpha and NF-kappaB in PC-3 and C4-2B cells. CONCLUSIONS:Daidzein could be the component of soy that protects against genistein-induced metastasis. Daidzein inhibited cell growth and synergized with radiation, affecting APE1/Ref-1, NF-kappaB and HIF-1alpha, but at lower levels than genistein and soy, in AR+ and AR- PCa cells, suggesting it is an AR-independent mechanism.
Authors: Coral A Lamartiniere; Michelle S Cotroneo; Wayne A Fritz; Jun Wang; Roycelynn Mentor-Marcel; Ada Elgavish Journal: J Nutr Date: 2002-03 Impact factor: 4.798
Authors: Joanna Wietrzyk; Maria Mazurkiewicz; Janusz Madej; Stanisław Dzimira; Grzegorz Grynkiewicz; Czesław Radzikowski; Adam Opolski Journal: Med Sci Monit Date: 2004-10-26
Authors: Gregory P Swanson; Michael A Hussey; Catherine M Tangen; Joseph Chin; Edward Messing; Edith Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford Journal: J Clin Oncol Date: 2007-06-01 Impact factor: 44.544
Authors: Gilda G Hillman; Vinita Singh-Gupta; Lindsay Runyan; Christopher K Yunker; Joseph T Rakowski; Fazlul H Sarkar; Steven Miller; Shirish M Gadgeel; Seema Sethi; Michael C Joiner; Andre A Konski Journal: Radiother Oncol Date: 2011-11-11 Impact factor: 6.280
Authors: Brante P Sampey; Terrence D Lewis; Claire S Barbier; Liza Makowski; David G Kaufman Journal: Exp Mol Pathol Date: 2011-01-31 Impact factor: 3.362
Authors: Benjamin A Mooso; Ruth L Vinall; Clifford G Tepper; Rosalinda M Savoy; Jean P Cheung; Sheetal Singh; Salma Siddiqui; Yu Wang; Roble G Bedolla; Anthony Martinez; Maria Mudryj; Hsing-Jien Kung; Ralph W Devere White; Paramita M Ghosh Journal: Endocr Relat Cancer Date: 2012-11-09 Impact factor: 5.678
Authors: Vinita Singh-Gupta; Sanjeev Banerjee; Christopher K Yunker; Joseph T Rakowski; Michael C Joiner; Andre A Konski; Fazlul H Sarkar; Gilda G Hillman Journal: Cancer Lett Date: 2011-12-09 Impact factor: 8.679
Authors: Gilda Gali Hillman; Vinita Singh-Gupta; Areen K Al-Bashir; Christopher K Yunker; Michael C Joiner; Fazlul H Sarkar; Judith Abrams; E Mark Haacke Journal: Transl Oncol Date: 2011-04-01 Impact factor: 4.243
Authors: Julius E Thigpen; Kenneth D R Setchell; Grace E Kissling; Jacqueline Locklear; Gordon F Caviness; Tanya Whiteside; Scott M Belcher; Nadine M Brown; Bradley J Collins; Fred B Lih; Kenneth B Tomer; Elizabeth Padilla-Banks; Luísa Camacho; Floyd G Adsit; Mary Grant Journal: J Am Assoc Lab Anim Sci Date: 2013-03 Impact factor: 1.232